|
|
 | | | |
- close
- close
- close
- close
Perrigo Company (PRGO) |
QUOTE AND NEWS
Benzinga
Mar 1
Comment
Below are the top drug related products stocks on the NYSE and the NASDAQ in terms of earnings per share.
The trailing-twelve-month earnings per share at Perrigo Company (NASDAQ: PRGO) is $3.67. PRGO's operating margin for the same period is...
PR Newswire
Feb 28
Comment
ALLEGAN, Mich., Feb. 28, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced its Chairman & CEO Joseph Papa will present at the RBC Capital Markets' Healthcare Conference on Wednesday, February 29th, at 3:30 PM (EST) at The New
Market Intelligence Center
Feb 28
Comment
Perrigo (NASDAQ: PRGO) rose Tuesday a day ahead of the stock's trading ex-dividend for for a payment of 8 cents payable on March 20.
An April 90/85 Out of The Money Bull-Put Credit Spread looks like an attractive way to play PRGO today. This...
Market Intelligence Center
Feb 16
Comment
Perrigo (NASDAQ:PRGO) closed Wednesday's deflating trading session at $93.50. In the past year, the stock has hit a 52-week low of $71.54 and 52-week high of $104.70. Perrigo (PRGO) stock has been showing support around $92.13 and resistance in...
Benzinga
Feb 14
Comment
Perrigo Company (Nasdaq: PRGO) announced that it has begun shipping Loratadine-D 12 hour extended release tablets, the store brand equivalent to Schering-Plough's Claritin-D® 12 hour extended release tablets.
Claritin-D® 12 is indicated for...
Market Intelligence Center
Feb 10
Comment
Perrigo (NASDAQ: PRGO) closed Thursday's trading session at $94.05. In the past year, the stock has hit a 52-week low of $70.94 and 52-week high of $104.70. Perrigo (PRGO) stock has been showing support around $92.38 and resistance in the $95.28...
Benzinga
Feb 8
Comment
Collins Stewart has published a research report on Perrigo (NASDAQ: PRGO) saying that the company should be bought on weakness.
In the report, Collins Stewart writes, "PRGO already knew about the 14 week quarter (versus 13 week quarter in...
PR Newswire
Feb 8
Comment
ALLEGAN, Mich., Feb. 8, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo CFO Judy Brown will present at the Leerink Swann 2012 Global Healthcare Conference on Wednesday, February 15th, at 2:30 PM (EST) at the
TheStreet.com
Feb 7
Comment
NEW YORK (TheStreet) -- Shares of health care companies Medco and Perrigo were among the best S&P 500 performers midday Tuesday while another health care company, Becton Dickinson , was among the worst.
The S&P 500 rose 2.28 points to...
Benzinga
Feb 7
Comment
JP Morgan remains Neutral-rated on Perrigo Company (NASDAQ: PRGO) as the company delivers modest beat in both top and bottom lines.
JP Morgan says, "Perrigo reported a modest top-line and EPS beat with results once again driven by the...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
